⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 29 August, 2019    By - Dr Clemens
Ketamine Infusions for Chronic Pain

AUTHORS: Orhurhu, Vwaire MD, MPH et al Anesthesia & Analgesia: July 2019 – Volume 129 – Issue 1 – p 241-254 BACKGROUND: IV ketamine is widely used to treat patients with chronic pain, yet the long-term impact remains uncertain. We synthesized evidence from randomized control trials to investigate the effectiveness of IV ketamine infusions for pain […]

Read More
Uncategorized Published - 29 August, 2019    By - Dr Clemens
Overall Competency Evaluations Favor Female Fellows

Author: Michael Vlessides Anesthesiology News Global scores from a 360-degree evaluation tool revealed higher overall scores for female fellows than male fellows, and both male and female evaluators also scored the women more positively in several competency domains. “In the past, gender bias has been a potential issue that has affected how medical students, residents […]

Read More
Uncategorized Published - 29 August, 2019    By - Dr Clemens
Health Threats Don’t End for Some Sepsis Survivors

Health Day Sepsis is a life-threatening infection that lands its victims in the hospital, but the dangers don’t end for survivors who have high levels of inflammation long after being discharged, a new study finds. “Sepsis is the leading cause of death among hospitalized patients. Patients discharged from the hospital aren’t out of the woods […]

Read More
Uncategorized Published - 29 August, 2019    By - Dr Clemens
New Guidelines on Obesity Hypoventilation Syndrome Released

By Kelly Young The American Thoracic Society has issued new guidelines on evaluating and managing patients with obesity hypoventilation syndrome (OHS), defined as obesity in the presence of sleep disordered breathing and awake daytime hypercapnia after other causes of hypoventilation are ruled out. The guidelines, published in the American Journal of Respiratory and Critical Care Medicine, […]

Read More
Uncategorized Published - 29 August, 2019    By - Dr Clemens
Oklahoma’s $572 million opioid judgment against Johnson & Johnson: Here’s what comes next

Author: Geoff Mulvihill, Associated Press Oklahoma’s $572 million judgment against Johnson & Johnson will likely be followed by more trials and legal settlements seeking to hold a drug company accountable for a U.S. opioid crisis that has ripped apart lives, families and communities. Monday’s ruling could help shape negotiations over roughly 1,500 similar lawsuits filed by state, local and […]

Read More